165 related articles for article (PubMed ID: 6849783)
1. Labetalol disposition and concentration-effect relationships during pregnancy.
Rubin PC; Butters L; Kelman AW; Fitzsimons C; Reid JL
Br J Clin Pharmacol; 1983 Apr; 15(4):465-70. PubMed ID: 6849783
[TBL] [Abstract][Full Text] [Related]
2. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
[TBL] [Abstract][Full Text] [Related]
3. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
[TBL] [Abstract][Full Text] [Related]
4. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
[TBL] [Abstract][Full Text] [Related]
5. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
[TBL] [Abstract][Full Text] [Related]
6. Use of labetalol and methyldopa in pregnancy-induced hypertension.
Lamming GD; Symonds EB
Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
[TBL] [Abstract][Full Text] [Related]
7. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
[TBL] [Abstract][Full Text] [Related]
8. The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.
Daneshmend TK; Roberts CJ
Br J Clin Pharmacol; 1984 Sep; 18(3):393-400. PubMed ID: 6487478
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
Lamming GD; Broughton Pipkin F; Symonds EM
Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
[TBL] [Abstract][Full Text] [Related]
10. Labetalol pharmacokinetics in pregnancy-induced hypertension.
Rogers RC; Sibai BM; Whybrew WD
Am J Obstet Gynecol; 1990 Feb; 162(2):362-6. PubMed ID: 2309815
[TBL] [Abstract][Full Text] [Related]
11. Single-dose pharmacokinetics of labetalol in healthy young men.
Nyberg G; Hansson R; Tietz F
Acta Med Scand Suppl; 1982; 665():67-73. PubMed ID: 6961762
[TBL] [Abstract][Full Text] [Related]
12. The disposition and dynamics of labetalol in patients on dialysis.
Halstenson CE; Opsahl JA; Pence TV; Luke DR; Sirgo MA; Plachetka JR; Abraham PA; Matzke GR
Clin Pharmacol Ther; 1986 Oct; 40(4):462-8. PubMed ID: 3757409
[TBL] [Abstract][Full Text] [Related]
13. Single dose of labetalol in hypertensive pregnancy: effects on maternal hemodynamics and uterine and fetal flow velocity waveforms.
Pirhonen JP; Erkkola RU; Mäkinen JI; Ekblad UU
J Perinat Med; 1991; 19(3):167-71. PubMed ID: 1748937
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of labetalol.
McNeil JJ; Louis WJ
Clin Pharmacokinet; 1984; 9(2):157-67. PubMed ID: 6370541
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.
McNeil JJ; Anderson AE; Louis WJ; Morgan DJ
Br J Clin Pharmacol; 1979; 8(Suppl 2):157S-161S. PubMed ID: 526397
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, beta-adrenoceptor blockade and anti-hypertensive action of labetalol during chronic oral treatment.
Sanders GL; Davies DM; Rawlins MD
Br J Clin Pharmacol; 1980 Aug; 10(2):121-6. PubMed ID: 6252915
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of labetalol in healthy volunteers.
Kanto J; Allonen H; Kleimola T; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1981 Jan; 19(1):41-4. PubMed ID: 7203731
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
Elliott HL; Meredith PA; Sumner DJ; Reid JL
Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
Michael CA
Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
[TBL] [Abstract][Full Text] [Related]
20. The influence of pregnancy on drug action: concentration-effect modelling with propranolol.
Rubin PC; Butters L; McCabe R; Kelman A
Clin Sci (Lond); 1987 Jul; 73(1):47-52. PubMed ID: 3608376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
